SCHEMBL6479522

SCHEMBL6479522

O=[C]c1ccc(C2CCOc3ccccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.37
ITGB2 P05107 1/20 0.34
ICAM1 P05362 1/20 0.34
ITGAL P20701 1/20 0.34
SSTR4 P31391 1/20 0.33
CYP19A1 P11511 3/20 0.33
KCNH2 Q12809 2/20 0.32
SLC6A2 P23975 3/20 0.32
SLC6A4 P31645 3/20 0.32
SLC6A3 Q01959 3/20 0.32
GRM5 P41594 1/20 0.32
LMNA P02545 2/20 0.32
CRHBP P24387 2/20 0.32
CRHR2 Q13324 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 1/20 0.32
OPRD1 P41143 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29543994 0.82 OPRD1 (0.43) PIK3CAITGB2ICAM1ITGALCYP19A1
SCHEMBL2485975 0.82 OPRD1 (0.43) PIK3CAITGB2ICAM1ITGALCYP19A1
SCHEMBL11724954 0.80 ESR1 (0.46) PIK3CAITGB2ICAM1ITGAL
SCHEMBL29100528 0.80 ADRA2A (0.42)
SCHEMBL6479526 0.79 PIK3CA (0.37) PIK3CAITGB2ICAM1ITGALSSTR4
SCHEMBL20856119 0.76 CYP19A1 (0.51) CYP19A1KCNH2
Methylamine SCHEMBL28010895 0.76 ESR1 (0.43) PIK3CASSTR4
SCHEMBL20856129 0.75 PIK3CA (0.43) PIK3CAITGB2ICAM1ITGALKCNH2
SCHEMBL22332700 0.75 PIK3CA (0.43) PIK3CAITGB2ICAM1ITGALKCNH2
SCHEMBL21092244 0.74 ESR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed